FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

265 Suicidal Reports on GLP-1 Drugs: Reuters

According to Reuters, FDA says it is doing a thorough review of 265 reports of suicidal thoughts or behavior that may be associated with taking Novo N...

latest-news-card-1
Medical Devices

Physiologic Closed-Loop Control Guidance

FDA publishes a guidance on technical considerations for medical devices that use physiologic closed-loop control technology with recommendations for ...

latest-news-card-1

Graft-vs-Host Product Development Guidance

FDA publishes a draft guidance to assist sponsors in developing various types of products to prevent or treat graft-versus-host disease.

latest-news-card-1
Human Drugs

FDA Approves New Depression Drug

FDA approves a Fabre-Kramer Pharmaceuticals NDA for Exxua (gepirone hydrochloride extended-release tablets) for treating major depressive disorder in ...

latest-news-card-1
Human Drugs

FDA OKs Pfizers Bosulif for Pediatric CML

FDA approves a new indication for Pfizers Bosulif to treat some pediatric patients with chronic myelogenous leukemia.

latest-news-card-1
Human Drugs

Ileus Added to Ozempic Label Adverse Effects

CBS News says FDA has approved a labeling change for Novo Nordisks Ozempic to acknowledge reports of ileus following use of the drug.

latest-news-card-1
Human Drugs

Gilead Ends AML Trial of Magrolimab

Gilead says it ended the ENHANCE-2 trial of magrolimab in acute myeloid leukemia with TP53 mutations after determining it would not provide a benefit ...

latest-news-card-1
Human Drugs

Prescription Information Modernization Bill

Sens. Mullins and Booker introduce bipartisan legislation to permit electronic transmission of drug prescribing information to healthcare professional...

latest-news-card-1
Human Drugs

Eye Dilation Reversal Drops Approved

FDA approves a Viatris and Ocuphire Pharma NDA for Ryzumvi (phentolamine ophthalmic solution) 0.75% for treating pharmacologically-induced mydriasis (...

latest-news-card-1
Medical Devices

Boston Scientifics AVVIGO+ Guidance Device Cleared

FDA clears a Boston Scientific 510(k) for its AVVIGO+ Multi-Modality Guidance System, which the company describes as a streamlined platform that enhan...